Physician profile
Joshua Baker
NPI 1972623692
$35,756.24
in general payments reported to CMS, 2019-2025
18 companies · $1,871 in 2025
The $1,871 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $25.22 · 2021: $142 · 2022: $31K · 2023: $272 · 2024: $2,229 · 2025: $1,871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,200 · Food and Beverage: $1,172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,199.53 |
| Food and Beverage | $1,172.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biostable Science & Engineering | $30,476.16 | 2022 | |
| Edwards Lifesciences Corporation | $2,204.06 | 2022-2025 | Evoque |
| W. L. Gore & Associates, INC. | $1,180.75 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Abbott Laboratories | $655.49 | 2019-2025 | Tendyne |
| Baxter Healthcare | $309.88 | 2019-2022 | |
| Medtronic Vascular, INC. | $205.86 | 2019-2020 | |
| Livanova USA, INC. | $120.37 | 2019 | |
| Medtronic, INC. | $117.44 | 2021-2023 | Corevalve Evolut R |
| Genzyme Corporation | $115.09 | 2023 | |
| Depuy Synthes Sales INC. | $112.34 | 2023-2025 | Matrixrib |
| Getinge USA Sales, LLC | $80.56 | 2023-2024 | Cardioroot, Intergard, Vasoview Hemopro 2 |
| Abiomed | $60.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $55.49 | 2021-2024 | Sternalock Blu System |
| Covidien LP | $18.82 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.15 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $14.80 | 2019 | |
| Atricure, INC. | $12.98 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.